You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Claims for Patent: 11,096,913

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,096,913

Title:	High-stability packaged solutions of T4 thyroid hormone
Abstract:	The invention relates to highly stable alcohol-free, water-glycerol solutions of T4 thyroid hormone, with a reduced amount of T3 impurity, packaged via specific container arrangements. The containers are multi-barrier ones, in which a number of layers of specific materials separate the solution from contact with the external environment.
Inventor(s):	Tiziano Fossati, Lorenzo Bellorini, Marco Pizzutti
Assignee:	Altergon SA
Application Number:	US16/697,924
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 11,096,913
Patent Claims:	1. A pharmaceutical preparation of T4 thyroid hormone comprising a container pre-filled with a liquid pharmaceutical composition consisting essentially of: T4 thyroid hormone dissolved in an alcohol-free and preservative-free solution of 85% glycerol in water, and optionally T3 thyroid hormone in an amount of less than 2.5%; wherein the container is a single dose plastic container. 2. The pharmaceutical preparation of claim 1, wherein the liquid pharmaceutical composition contains optionally T3 thyroid hormone in an amount of less than 2.0%. 3. The pharmaceutical preparation of claim 2, wherein the liquid pharmaceutical composition contains optionally T3 thyroid hormone in an amount of less than 1.8%. 4. The pharmaceutical preparation of claim 1, wherein the T4 thyroid hormone to glycerol weight ratio in the alcohol-free solution is in the range from about 4 to about 400 ppm. 5. The pharmaceutical preparation of claim 1, wherein a single dose unit is 5 to 350 μg of T4 thyroid hormone. 6. The pharmaceutical preparation of claim 5, wherein a single dose unit is 5 to 250 μg of T4 thyroid hormone. 7. The pharmaceutical preparation of claim 1, wherein the plastic container has a thickness of between about 150 and about 1000 μm. 8. The pharmaceutical preparation of claim 7, wherein the plastic container has a thickness of between about 200 and about 800 μm. 9. The pharmaceutical preparation of claim 1, wherein the plastic container is made of one-component LDPE plastic.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.